Fed. Circ. Affirms Another AbbVie Win In Humira Patent Case
The Federal Circuit on Wednesday upheld a lower court's July decision invalidating a Mathilda and Terence Kennedy Institute of Rheumatology Trust arthritis treatment patent, freeing AbbVie Inc. from having to pay...To view the full article, register now.
Already a subscriber? Click here to view full article